UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Learning from the past: development of safe and effective COVID-19 vaccines

Nature reviews. Microbiology, 2021-03, Vol.19 (3), p.211-219

2021

Volltextzugriff (PDF)

Neutralizing antibodies for the prevention and treatment of COVID-19

Cellular & molecular immunology, 2021-10, Vol.18 (10), p.2293-2306

2021

Volltextzugriff (PDF)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Cellular & molecular immunology, 2020-06, Vol.17 (6), p.613-620

2020

Volltextzugriff (PDF)

SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies

Signal transduction and targeted therapy, 2021-02, Vol.6 (1), p.95-95, Article 95

2021

Volltextzugriff (PDF)

Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses

Frontiers in microbiology, 2020-02, Vol.11, p.298-298

2020

Volltextzugriff (PDF)

An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies

Emerging microbes & infections, 2020-01, Vol.9 (1), p.275-277

2020

Volltextzugriff (PDF)

Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China

Microbes and infection, 2020-03, Vol.22 (2), p.74-79

2020

Volltextzugriff (PDF)

Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry

Journal of virology, 2020-02, Vol.94 (5)

2020

Volltextzugriff (PDF)

Prospects for a MERS-CoV spike vaccine

Expert review of vaccines, 2018-08, Vol.17 (8), p.677-686

2018

Volltextzugriff (PDF)

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

Cell research, 2020-04, Vol.30 (4), p.343-355

2020

Volltextzugriff (PDF)

Recent advances in the detection of respiratory virus infection in humans

Journal of medical virology, 2020-04, Vol.92 (4), p.408-417

2020

Volltextzugriff (PDF)

Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction

Biophysical journal, 2021-03, Vol.120 (6), p.1011-1019

2021

Volltextzugriff (PDF)

A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection

Virology (New York, N.Y.), 2016-12, Vol.499, p.375-382

2016

Volltextzugriff (PDF)

Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain

Viruses, 2019-01, Vol.11 (1), p.60

2019

Volltextzugriff (PDF)

Allocation strategy of medical supplies during a public health emergency: a tripartite evolutionary game perspective

Scientific reports, 2023-06, Vol.13 (1), p.9571-9571, Article 9571

2023

Volltextzugriff (PDF)

Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus

Proceedings of the National Academy of Sciences - PNAS, 2014-08, Vol.111 (34), p.12516-12521

2014

Volltextzugriff (PDF)

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2

Cell research, 2020-10, Vol.30 (10), p.932-935

2020

Volltextzugriff (PDF)

Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines

Expert review of vaccines, 2023, Vol.22 (1), p.422-439

2023

Volltextzugriff (PDF)

The spike protein of SARS-CoV - a target for vaccine and therapeutic development

Nature reviews. Microbiology, 2009-03, Vol.7 (3), p.226-236

2009

Volltextzugriff (PDF)

Neutralizing antibodies for the treatment of COVID-19

Nature biomedical engineering, 2020-12, Vol.4 (12), p.1134-1139

2020

Volltextzugriff (PDF)

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development

Microbes and infection, 2020-07, Vol.22 (6-7), p.245-253

2020

Volltextzugriff (PDF)

MERS Coronavirus: An Emerging Zoonotic Virus

Viruses, 2019-07, Vol.11 (7), p.663

2019

Volltextzugriff (PDF)

The development of Nanosota - 1 as anti-SARS-CoV-2 nanobody drug candidates

eLife, 2021-08, Vol.10

2021

Volltextzugriff (PDF)

Receptor usage and cell entry of porcine epidemic diarrhea coronavirus

Journal of virology, 2015-06, Vol.89 (11), p.6121-6125

2015

Volltextzugriff (PDF)

Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

Nature communications, 2014-01, Vol.5 (1), p.3067, Article 3067

2014

Volltextzugriff (PDF)

1 – 25 von 285

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(265)
Mit Volltextzugriff
(260)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(223)
Life Sciences & Biomedicine
(169)
Humans
(131)
Animals
(115)
Immunology
(67)
Mice
(61)
Virology
(60)
Vaccines
(55)
Female
(47)
Proteins
(47)
Mice, Inbred Balb C
(40)
Viral Vaccines - Immunology
(40)
Infections
(38)
Receptor-Binding Domain
(38)
Science & Technology - Other Topics
(37)
Microbiology
(35)
Spike Protein
(34)
Viruses
(33)
Antibodies, Neutralizing - Immunology
(32)
Coronaviruses
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Learning from the past: development of safe and effective COVID-19 vaccines

Neutralizing antibodies for the prevention and treatment of COVID-19

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies

Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses

An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies

Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China

Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry

Prospects for a MERS-CoV spike vaccine

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

Recent advances in the detection of respiratory virus infection in humans

Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction

A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection

Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain

Allocation strategy of medical supplies during a public health emergency: a tripartite evolutionary game perspective

Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2

Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines

The spike protein of SARS-CoV - a target for vaccine and therapeutic development

Neutralizing antibodies for the treatment of COVID-19

From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development

MERS Coronavirus: An Emerging Zoonotic Virus

The development of Nanosota - 1 as anti-SARS-CoV-2 nanobody drug candidates

Receptor usage and cell entry of porcine epidemic diarrhea coronavirus

Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

Suchergebnisse filtern